British Journal of Haematology · 1979 · 50 citations · 21 references
MedicineHematologySurgeryGeneral SurgeryHematopathologySurgical OncologyAnemiaHematologic DisordersHematologic PathologyHematopoietic NeoplasmsSplenic PathologyHematologic Outcome AssessmentLate MortalityPostoperative MortalitySplenic Hemorrhage
The available data on 321 published cases of splenectomy in agnogenic myeloid metaplasia were reviewed. Anaemia and thrombopenia were the most common indications for this operation. Patients reported after 1940 had a median postoperative survival of 13 months. Their postoperative mortality was 7.5% after 2 d and 25.7% after 3 months. The postoperative mortality was significantly higher when the weight of the spleen exceeded 2000 g, or in patients with platelet count less than 70 X 10(9)/l. The most common causes of death were infections (34.4%), cardiac or thromboembolic events (26.4%) and haemorrhage (17.6%). Leukaemic transformation was reported in 11.2% of the cases.
21
James W. Linman, Frank H. Bethell · The American Journal of Medicine · 1957 · 70 citations
Splenectomy for Myeloid Metaplasia of the Spleen
Thomas W. Green, C. Lockard Conley, L. L. Ashburn et al. · New England Journal of Medicine · 1953 · 67 citations
Medicine, Hematology, Surgery +14
Splenectomy for Hematologic Disorders
Seymour I. Schwartz · Archives of Surgery · 1970 · 67 citations
Medicine, Hematology, Surgery +12